Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

New Synthetic Opioids: Clinical Considerations and Dangers
Amber N. Edinoff, David Martinez Garza, Stephen P. Vining, et al.
Pain and Therapy (2023) Vol. 12, Iss. 2, pp. 399-421
Open Access | Times Cited: 24

Showing 24 citing articles:

Early identification of the use of potent benzylbenzimidazoles (nitazenes) through wastewater analysis: Two years of data from 22 countries
Richard Bade, Dhayaalini Nadarajan, Wayne Hall, et al.
Addiction (2025)
Open Access | Times Cited: 1
Accidental protonitazene intoxication: clinical management and detection of a novel opioid
Jonathan Meltzer, Alexandra Boucher, Sabine Cohen, et al.
BMJ Case Reports (2025) Vol. 18, Iss. 3, pp. e261722-e261722
Closed Access | Times Cited: 1
Tackling new psychoactive substances through metabolomics: UHPLC-HRMS study on natural and synthetic opioids in male and female murine models
Gaia Di Francesco, Camilla Montesano, Flaminia Vincenti, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 4
Testing for protonitazene in human hair using LC–MS-MS
Pascal Kintz, Alice Ameline, Laurie Gheddar, et al.
Journal of Analytical Toxicology (2024) Vol. 48, Iss. 8, pp. 630-635
Closed Access | Times Cited: 4
The analytical tools for new psychoactive substances identification and quantification
D. Gallart-Mateu, Miguel de la Guárdia
Comprehensive analytical chemistry (2025)
Closed Access
New psychoactive substances: Pharmacology and impact on human health
Rebeca Vidal, Ma Esther O’Shea Gaya, M López, et al.
Comprehensive analytical chemistry (2025)
Closed Access
Navigating nitazenes: A pharmacological and toxicological overview of new synthetic opioids with a 2-benzylbenzimidazole core
Marthe M. Vandeputte, Christophe P. Stove
Neuropharmacology (2025), pp. 110470-110470
Closed Access
First evidence in an oversea French department of the deadly risk of protonitazene use: about 5 post mortem cases
Christophe Maruéjouls, Alice Ameline, Laurie Gheddar, et al.
International Journal of Legal Medicine (2024)
Closed Access | Times Cited: 3
Hazardous Materials from Threats to Safety: Molecularly Imprinted Polymers as Versatile Safeguarding Platforms
Ana-Mihaela Gavrilă, Aurel Diacon, Tanţa-Verona Iordache, et al.
Polymers (2024) Vol. 16, Iss. 19, pp. 2699-2699
Open Access | Times Cited: 2
How Should Risks and Benefits of Short-Acting Opioids Be Evaluated in the Care of Inpatients With OUD?
Kathryn Dong, Katherine Duthie
The AMA Journal of Ethic (2024) Vol. 26, Iss. 7, pp. E512-519
Open Access | Times Cited: 1
Respiratory Depression Associated with Opioids: A Narrative Review
Mellar P. Davis, Sandra DiScala, Amy L. Davis
Current Treatment Options in Oncology (2024) Vol. 25, Iss. 11, pp. 1438-1450
Closed Access | Times Cited: 1
Nitazene opioids and the heart: Identification of a cardiac ion channel target for illicit nitazene opioids
Jules C. Hancox, Yibo Wang, Caroline S. Copeland, et al.
Journal of Molecular and Cellular Cardiology Plus (2024) Vol. 10, pp. 100118-100118
Open Access | Times Cited: 1
Enhancing Forensic Laboratories Through University Collaboration: Obtaining Conclusive Reports and Reference Materials via NMR
Luciano C. Arantes, Dâmaris Silveira, Gabriel Magno Sousa de Azerêdo, et al.
Magnetic Resonance in Chemistry (2024)
Open Access | Times Cited: 1
New Psychoactive Substances (NPS): A Rising Pandemic in the Mental Health Field?
Stefania Chiappini, Clara Cavallotto, Tommaso Piro, et al.
Sustainable development goals series (2024), pp. 129-140
Closed Access | Times Cited: 1
What’s New on the Street?
Pamela Harris-Haman
Critical Care Nursing Clinics of North America (2024) Vol. 36, Iss. 2, pp. 211-221
Closed Access
Informing evidence-based medicine for opioid use disorder using pharmacoeconomic studies
Ali Jalali
Expert Review of Pharmacoeconomics & Outcomes Research (2024) Vol. 24, Iss. 5, pp. 599-611
Closed Access
Implementation of Medications for Alcohol and Opioid Use Disorders in a Value-Based Organization-Unlocking Value by Addressing Unmet Needs for Medicaid and Dually-Eligible Beneficiaries
David Dayan-Rosenman, Steven Spencer
Population Health Management (2024) Vol. 27, Iss. 4, pp. 275-283
Closed Access
Disrupted Circadian Rhythms and Substance Use Disorders: A Narrative Review
Pallavi Sharma, Randy J. Nelson
Clocks & Sleep (2024) Vol. 6, Iss. 3, pp. 446-467
Open Access
New synthetic opioids
Daniela Wissenbach, Dirk K. Wissenbach, Hans H. Maurer
Comprehensive analytical chemistry (2024)
Closed Access
NPS – Drugs to circumvent laws
Raquel Capilla Loureiro Alves Santana, Gleicielle Tozzi Wurzler, Ananda da Silva Antonio, et al.
Comprehensive analytical chemistry (2024)
Closed Access
Use Patterns of Classic, Novel, and Herbal Opioids
Elisabeth Prevete, Natasha L. Mason, Kim P. C. Kuypers, et al.
Emerging Trends in Drugs Addictions and Health (2024), pp. 100166-100166
Open Access
The Opioid Overdose Epidemic and Response
Jeremy Weleff, Laila Knio, Noah A. Capurso
Elsevier eBooks (2023)
Closed Access | Times Cited: 1
Year 2023 in review - Pain management
Jiří Málek
Anesteziologie a intenzivní medicína (2023) Vol. 34, Iss. 5, pp. 222-226
Closed Access
Desafíos en torno al fentanilo: Sobredosis y Enfoques Terapéuticos
Jeniffer Gonzalez Hernandez, Alfonso Martinez Visbal, Chelsea Toloza Salina
Revista Ciencias Biomédicas (2023) Vol. 12, Iss. 1, pp. 23-31
Open Access
Page 1

Scroll to top